Literature Review: Hepatocellular Carcinoma (HCC)
Authors
Luthfi Zakiyyah , Muhammad Fauzan , Lalu Maulana Azmi Gifari , Hagia Faranajhia , Ajeng Ayu Putri , Anang Hermansyah , Tazkiyah ArafahDOI:
10.29303/jbt.v24i4.7761Published:
2024-11-21Issue:
Vol. 24 No. 4 (2024): Oktober - DesemberArticles
Downloads
How to Cite
Downloads
Metrics
Abstract
Hepatocellular Carcinoma (HCC) is a type of primary liver cancer which is a fatal disease. Globally, Hepatocellular Carcinoma (HCC) is the dominant type of liver cancer, accounting for around 75% of the total incidence. HCC incidents are mostly found in Asia and Africa. In general, the causes of HCC include a history of hepatic cirrhosis, chronic hepatitis B infection, hepatitis C infection, autoimmune hepatitis, excessive alcohol consumption, obesity, smoking, non-alcoholic steatohepatitis (NASH), and diabetes mellitus. There are three types of therapy including surgery, locoregional, and systemic. The therapy is also divided into invasive, minimally invasive, and non-invasive therapy. This literature review aims to facilitate the review of the Hepatocellular Carcinoma. Scientific related questions, databases to be used, selection of keywords, inclusion and exclusion criteria, definition of results and conclusions of selected articles are all elements included in this research search strategy. At the end e met some articles that fit the criteria and conclude that is a deadly disease with high mortality and morbidity because in the early stage HCC is generally asymptomatic.
References
Bittaye, S. O., Njie, R., Tekanyi, M., Kambi, A., Tamba, S., Fatty, G., ... & Sisawo, M. M. (2020). Clinical manifestation, staging and prognosis of hepatocellular carcinoma in Gambian patients. Cancer Research, 80(16_Supplement), 2346-2346.
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 68(6), 394-424. https://doi.org/10.3322/caac.21492.
Harding, J. J., Abu-Zeinah, G., Chou, J. F., Owen, D. H., Ly, M., Lowery, M. A., ... & Abou-Alfa, G. K. (2018). Frequency, morbidity, and mortality of bone metastases in advanced hepatocellular carcinoma. Journal of the National Comprehensive Cancer Network, 16(1), 50-58. https://doi.org/10.6004/jnccn.2017.7024.
Hasan, I., Loho, I. M., & Setiawan, P. B. (2021). Konsensus terapi sistemik karsinoma sel hati di Indonesia. Perhimpunan Peneliti Hati Indonesia.
Hasan, I., Loho, I. M., Lesmana, C. R., & Gani, R. A. (2020). Fungsi hati dan jenis terapi merupakan prediktor kesintasan pasien karsinoma sel hati. Liver, 9, 30-2020. https://doi.org/10.7454/jpdi.v7i3.460
Hernandez, B. Y., Zhu, X., Nagata, M., Loo, L., Chan, O., & Wong, L. L. (2023). Cyanotoxin exposure and hepatocellular carcinoma. Toxicology, 487, 153470. https://doi.org/10.1016/j.tox.2023.153470.
Jasirwan, C. O. M., Hasan, I., Sulaiman, A. S., Lesmana, C. R. A., Kurniawan, J., Kalista, K. F., ... & Gani, R. A. (2020). Risk factors of mortality in the patients with hepatocellular carcinoma: A multicenter study in Indonesia. Current problems in cancer, 44(1), 100480. https://doi.org/10.1016/j.currproblcancer.2019.05.003
Kaya, E., Mazzolini, G. D., Yilmaz, Y., & Canbay, A. (2022, January). Prevention of hepatocellular carcinoma and monitoring of high-risk patients. In Hepatology Forum (Vol. 3, No. 1, p. 33). Turkish Association for the Study of the Liver. https://doi.org/10.14744/hf.2021.2021.0033.
Kılcı, B. M., İnce, V., Carr, B. I., Usta, S., Bağ, H. G., Şamdancı, E., ... & Yılmaz, S. (2023). Parameters Predicting Microvascular Invasion and Poor Differentiation in Hepatocellular Carcinoma Patients with Normal Alpha-fetoprotein Level Before Liver Transplantation. The Turkish Journal of Gastroenterology, 34(7), 753. https://doi.org/10.5152/tjg.2023.22538
Kulik, L., & El-Serag, H. B. (2019). Epidemiology and management of hepatocellular carcinoma. Gastroenterology, 156(2), 477-491. https://doi.org/10.1053/j.gastro.2018.08.065
McGlynn, K. A., Petrick, J. L., & El‐Serag, H. B. (2021). Epidemiology of hepatocellular carcinoma. Hepatology, 73, 4-13. https://doi.org/10.1002/hep.31288
Saputri, K. A., & Yudhono, D. T. (2022). Manajemen Jalan Nafas Pasien Heptocellurar Carsinoma Dengan Masalah Pola Nafas Tidak Efektif. JKM: Jurnal Keperawatan Merdeka, 2(2), 126-131. https://doi.org/10.36086/jkm.v2i2.1226
Sarveazad, A., Agah, S., Babahajian, A., Amini, N., & Bahardoust, M. (2019). Predictors of 5 year survival rate in hepatocellular carcinoma patients. Journal of Research in Medical Sciences, 24(1), 86. https://doi.org/10.4103/jrms.JRMS.
Singh, A. K., Kumar, R., & Pandey, A. K. (2018). Hepatocellular carcinoma: causes, mechanism of progression and biomarkers. Current chemical genomics and translational medicine, 12, 9. https://doi.org/10.2174/2213988501812010009
Yang, Z., Leng, K., & Shi, G. (2023). Causes of death among patients with hepatocellular carcinoma in United States from 2000 to 2018. Cancer Medicine, 12(12), 13076-13085. https://doi.org/10.1002/cam4.5986
Zelber-Sagi, S., Noureddin, M., & Shibolet, O. (2021). Lifestyle and hepatocellular carcinoma what is the evidence and prevention recommendations. Cancers, 14(1), 103. https://doi.org/10.3390/cancers14010103.
Zhang, X., Guan, L., Tian, H., Zeng, Z., Chen, J., Huang, D., ... & Li, Y. (2021). Risk factors and prevention of viral hepatitis-related hepatocellular carcinoma. Frontiers in oncology, 11, 686962. https://doi.org/10.3389/fonc.2021.686962.
License
Copyright (c) 2024 Luthfi Zakiyyah, Muhammad Fauzan, Lalu Maulana Azmi Gifari, Hagia Faranajhia, Ajeng Ayu Putri, Anang Hermansyah, Tazkiyah Arafah
This work is licensed under a Creative Commons Attribution 4.0 International License.
Jurnal Biologi Tropis is licensed under a Creative Commons Attribution 4.0 International License.
The copyright of the received article shall be assigned to the author as the owner of the paper. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.
Authors are permitted to disseminate published articles by sharing the link/DOI of the article at the journal. Authors are allowed to use their articles for any legal purposes deemed necessary without written permission from the journal with an acknowledgment of initial publication to this journal.